| BEFORE
THE CAMPAIGN: Uses.
Septrin is an antibacterial
agent. Septrin is effective in
vitro against a wide range
of Gram-positive and
Gram-negative organisms. It is
not active against Mycobacterium
tuberculosis. Mycoplasma
or Treponema pallidium. Pseudomonas
aeruginosa is usually
insensitive.
Septrin
is of value in the treatment of
the following:
Respiratory
tract: Acute and chronic
bronchitis, bronchiectasis, lobar
and broncho-pneumonia, otitis
media. sinusitis and prevention
and treatment of Pneumocystis
carinii pneumonitis.
Genito-urinary
tract: Acute upper and lower
urinary tract infections,
bacterial prostatitis and male
and female gonorrhoea.
Gastro-intestinal
tract: Typhoid and
paratyphoid fevers, chronic
carriage of Salmonella typhi
and paratyphi, cholera
as an adjunct to fluid and
electrolyte replacement and
shigellosis.
Skin
infections: Pyoderma,
abcesses and wound infections.
Other
bacterial infections: Acute
and chronic osteomyelitis, acute
brucellosis, septicaemias and
other infections caused by
sensitive organisms.
|
AFTER
THE CAMPAIGN: Uses.
Septrin should only be used
where, in the judgement of the
physician, the benefits of
treatment outweigh any possible
risks; consideration should be
given to the use of a single
effective antibacterial agent.
The
in vitro susceptibility of
bacteria to antibiotics varies
geographically and with time; the
local situation should always be
considered when selecting
antibiotic therapy.
Treatment
and prevention of Pneumocystis
carinii pneumonitis (see
Dosage and administration and
Side- and adverse effects).
Treatment
and prophylaxis of toxoplasmosis,
treatment of nocardiosis.
Urinary
tract infections; Acute
uncomplicated urinary tract
infections: Treatment of
urinary tract infections where
there is bacterial evidence of
sensitivity to co-trimoxazole and
good reason to prefer this
combination to a single
antibiotic.
Respiratory
tract infections; Otitis media: Acute
treatment of otitis media, where
there is good reason to prefer
co-trimoxazole to a single
antibiotic.
Treatment
of acute exacerbations of chronic
bronchitis, where there is
bacterial evidence of sensitivity
to co-trimoxazole and good reason
to prefer this combination to a
single antibiotic.
|